Delivery Order SPE2DB24D1006-SPE2DB25FCEPM
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Otezla 30 mg tablets, a medication used to treat certain autoimmune conditions. The contract has a firm fixed price and a ceiling value of $10,371.86, with a period of performance through April 23, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The contract has a ceiling value of $109,360.93 and a period of performance through April 17, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Otezla 30 mg tablet, a specialty medication, with a ceiling value of $2,939.22 and a performance period through August 7, 2024. As a delivery order, this award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which has a potential value of up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Otezla 30 mg tablets, a medication used to treat certain medical conditions. The contract has a ceiling value of $2,649.35 and a period of performance through April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Otezla 30 mg tablets, a medication used to treat certain medical conditions. The contract has a total ceiling value of $11,859.25 and a performance period ending on April 16, 2025. The contract is not set-aside and is a firm fixed-price delivery order. AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Otezla 30 mg tablets, a medication used to treat certain medical conditions. The contract has a ceiling value of $2,679.76 and a performance period ending on April 23, 2025. The contract is a firm-fixed-price delivery order, which indicates it was competed without any...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $15,739.44, is for the delivery of Otezla 30 mg tablets over a period ending on April 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distribution company. The contract is for the delivery of Otezla 30 mg tablets, a medication used to treat various conditions. The contract has a ceiling value of $11,244.48 and an ultimate completion date of September 20, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen is the prime contractor...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The contract has a ceiling value of $96,872.70 and a period of performance through August 27, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OTEZLA 30 MG TABLET 60S, a specialty medication, with a ceiling value of $7,937.62 and a performance period through December 27, 2024. The contract is a Firm Fixed Price, Indefinite Delivery vehicle, which enables efficient procurement of essential pharmaceutical products to support military healthcare programs. No...